Anti-beta-2 glycoprotein I antibodies (a major pathogenic antibody in APS) engage TLR4 signaling and trigger monocytes to express tissue factors and proinflammatory cytokines such as TNF-α and IL-1β (14). Here, TLR4 is linked to autoimmune polyendocrinopathy.